Loading clinical trials...
Loading clinical trials...
Clinical Study of Conservative Treatment for Atypical Endometrial Hyperplasia and Early Endometrial Cancer
Exploring the efficacy and pregnancy outcomes of conservative treatment for atypical endometrial hyperplasia and endometrial cancer. Study the factors related to predicting treatment efficacy.
Age
18 - 45 years
Sex
FEMALE
Healthy Volunteers
No
Start Date
December 1, 2023
Primary Completion Date
January 1, 2024
Completion Date
January 1, 2024
Last Updated
December 14, 2023
100
ESTIMATED participants
Lead Sponsor
Beijing Obstetrics and Gynecology Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions